Evidence map›Paper›PMID 34526512›Full record

ArticleNature communications2021

Chlamydia evasion of neutrophil host defense results in NLRP3 dependent myeloid-mediated sterile inflammation through the purinergic P2X7 receptor.

Chunfu Yang, Lei Lei, John W Marshall Collins, Michael Briones, Li Ma, Gail L Sturdevant, Hua Su, Anuj K Kashyap, David Dorward, Kevin W Bock and 10 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 43 citations in OpenAlex.

  1. HIV-1 andmSphere · 2026
    Article
  2. Article
  3. Inclusion Membrane Proteins ofMicroorganisms · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Infection and immunity · 2026
    Article
  9. Neutrophils at the Maternal-Fetal Interface: Agents of Protection or Destruction?American journal of reproductive immunology (New York, N.Y. : 1989) · 2025
    Review
  10. Article
  11. Development and Validation ofBio-protocol · 2025
    Article
  12. Pathogenic and Protective Roles of Neutrophils inPathogens (Basel, Switzerland) · 2025
    Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Recognition ofInfection and immunity · 2024
    Article
  18. Article
  19. Article
  20. Infection and immunity · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 3 countries.

Chunfu YangLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Lei LeiLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
John W Marshall CollinsLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Michael BrionesLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Li MaLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Gail L SturdevantLaboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA.
Hua SuLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Anuj K KashyapLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
David DorwardResearch Technology Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA.
Kevin W BockInfectious Disease Pathogenesis Section, Comparative Medicine Branch, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0001-9454-0937
Ian N MooreInfectious Disease Pathogenesis Section, Comparative Medicine Branch, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Christine BonnerNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Chih-Yu ChenNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Craig A MartensGenomics Unit, Research Technology Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA.
Stacy RicklefsGenomics Unit, Research Technology Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA.
Masahiro YamamotoDepartment of Immunoparasitology, Research Institute for Microbial Diseases (RIMD), Osaka University, Osaka, Japan.ORCID 0000-0002-6821-2785
Kiyoshi TakedaLaboratory of Mucosal Immunology, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan.
Yoichiro IwakuraInstitute for Biomedical Sciences, Tokyo University of Science, Tokyo, Japan.ORCID 0000-0002-9934-5775
Grant McClartyDepartment of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada.
Harlan D CaldwellLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. hcaldwell@niaid.nih.gov.ORCID 0000-0002-2018-8106
National Institutes of Health · USPublic Health Agency of Canada · CAThe University of Osaka · JPTokyo University of Science · JPUniversity of Manitoba · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chlamydia trachomatis infection causes severe inflammatory disease resulting in blindness and infertility. The pathophysiology of these diseases remains elusive but myeloid cell-associated inflammation has been implicated. Here we show NLRP3 inflammasome activation is essential for driving a macrophage-associated endometritis resulting in infertility by using a female mouse genital tract chlamydial infection model. We find the chlamydial parasitophorous vacuole protein CT135 triggers NLRP3 inflammasome activation via TLR2/MyD88 signaling as a pathogenic strategy to evade neutrophil host defense. Paradoxically, a consequence of CT135 mediated neutrophil killing results in a submucosal macrophage-associated endometritis driven by ATP/P2X7R induced NLRP3 inflammasome activation. Importantly, macrophage-associated immunopathology occurs independent of macrophage infection. We show chlamydial infection of neutrophils and epithelial cells produce elevated levels of extracellular ATP. We propose this source of ATP serves as a DAMP to activate submucosal macrophage NLRP3 inflammasome that drive damaging immunopathology. These findings offer a paradigm of sterile inflammation in infectious disease pathogenesis.

Indexed as

Adenosine TriphosphateAnimalsCells, CulturedChlamydiaChlamydia InfectionsDisease Models, AnimalFemaleHeLa CellsHost-Pathogen InteractionsHumansImmune EvasionInflammationMacrophagesMiceMice, Inbred C57BLMice, KnockoutAdenosine TriphosphateNLR Family, Pyrin Domain-Containing 3 ProteinReceptors, Purinergic P2X7

Identifiers

PMID34526512
PMCPMC8443728
OpenAlexW3201001243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.